Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Accenture
Fuji
Baxter
Covington
Medtronic
Express Scripts
Novartis
Fish and Richardson
Julphar

Generated: October 20, 2017

DrugPatentWatch Database Preview

Docosanol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for docosanol and what is the scope of docosanol patent protection?

Docosanol
is the generic ingredient in one branded drug marketed by Glaxosmithkline and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for docosanol. One supplier is listed for this compound.

Summary for Generic Name: docosanol

US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: see list3
Suppliers / Packagers: see list1
Bulk Api Vendors: see list74
Patent Applications: see list6,973
Drug Prices:see low prices
DailyMed Link:docosanol at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
ABREVA
docosanol
CREAM;TOPICAL020941-001Jul 25, 2000OTCYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: docosanol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
ABREVA
docosanol
CREAM;TOPICAL020941-001Jul 25, 2000► Subscribe► Subscribe
Glaxosmithkline
ABREVA
docosanol
CREAM;TOPICAL020941-001Jul 25, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
AstraZeneca
Johnson and Johnson
Cipla
QuintilesIMS
Deloitte
Teva
Harvard Business School
Cerilliant
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot